Batch Fee Sample Clauses

Batch Fee o For each Batch manufactured in accordance with Procedures, which complies with the Specifications and the other applicable terms of this Agreement, the Single Batch Fee will be *****. o If exactly two Batches are manufactured approximately in parallel/at approximately the same time, the Double Batch Fee for both Batches manufactured in accordance with Procedures and which comply with the Specifications and the other applicable terms of this Agreement, will be ***** for both batches. o The price of the leukocytes and plasma required to manufacture a Batch ordered under the Supply Agreement, if sourced from ARC, shall be ***** per Batch, which shall be payable under the Supply Agreement. Such price shall be inclusive of the tests that are normally performed on whole blood units including, testing of the donated blood for blood-borne pathogens to include: anti-HCV; HBsAg; anti-HIV 1&2; anti-HTLV Iⅈ HCV; HIV; HBV; Syphilis, CMV, HBV core antigen. The complete schedule of such tests included in the ***** price per Batch shall be detailed in the Quality Agreement. In the event that the Parties agree that additional tests (which are not normally performed on whole blood units) shall be performed on the Batches (e.g. Complete Blood Count) pricing shall be the subject of good faith negotiations between the Parties and shall reflect the actual cost of such testing to ARC. All Batch Fees will include corresponding MacroCure finished Products. The Single Batch Fees and the Double Batch Fees are exclusive of the ▇▇-▇▇ and plasma which are covered under separate agreement but are inclusive of the QC Assays listed below which are to be performed by ARC as part of the manufacturing of the Batches and Products. o There shall be no Single Batch Fee or Double Batch Fee for the Batch and/or Products manufactured as part of Technology Transfer. In addition, there shall be no payment by MacroCure for the first fifty (50) units of leukoctyes and plasma (including no payment for the relevant testing specified above) which are required to manufacture the Batches and/or Products manufactured as part of the Technology Transfer. ARC shall have the option of charging Macrocure for any leukoctyes and plasma (including no payment for the relevant testing specified above) which are required to manufacture the Batches and/or Products manufactured as part of the Technology Transfer above the first fifty (50) units manufactured as a part of the Technology Transfer. The price of such Pr...
View SourceView Similar (2)
Batch Fee. For each [ * ] Clinical Batch of Product Processed by I3 during the Term of this Agreement, NeoRx shall pay to I3 a fee based on the following schedule: BATCH PER WEEK PRICE PER BATCH -------------- --------------- [ * ] [ * ] The price per Batch includes the cost of labor, materials and overhead to manufacture and test the finished vials and is exclusive of the cost of (166)Holmium chloride, DOTMP, Shipment Boxes, Customer Service and distribution.
View Source
Batch Fee. (a) During the term of this Agreement, Warner shall pay Duramed a Batch Fee indicated on Schedule H; such Batch Fee includes Duramed's in-house labor costs in Manufacturing and Packaging the Product. Beginning with the first Contract Year and for each Contract Year thereafter, Duramed may increase the Batch Fee by an amount equal to the PPI Adjustment. The PPI Adjustment will be an amount equal to the average increase in the PPI over the immediately preceding twelve (12) month period. If the PPI is not available for any period, the most similar available index shall be used. (b) Upon expiration of Contract Year five, Duramed reserves the right to increase the Batch Fees for the remaining Contract Years, provided that Duramed can demonstrate to Warner that such increase is necessary to pass on actual cost increases ascribable to Duramed's direct, in-house labor and overhead costs, as determined in accordance with U.S. GAAP, for the Manufacture of the Product by providing documentation reasonably satisfactory to Warner.
View Source
Batch Fee. Client shall pay to OXB the applicable Batch Fee for each Batch in accordance with the payment schedule set out in Schedule 1. To the extent specified in an applicable Scope of Work or Work Order or Change Order, additional charges may be applied, for example for performance of Manufacturing processes or analytics which are not usually performed by OXB and costs of media validation studies where a filling process or container are required that are not encompassed under existing OXB media validations. A list of the items included in, and a nonexclusive list of items excluded from, the Batch Fee for each Batch is also shown in Schedule 1.
View Source
Batch Fee. For each batch of Product processed by ABC during the term of this Agreement, NeoRx shall pay to ABC a fee of (1) [*], (2) [*], and (3) [*]. The price per batch includes the cost of labor, material and overhead to manufacture and test the finished vials of Product, but is exclusive of the cost of 166 holmium chloride, DOTMP, ▇▇▇▇ radiation safety oversight and production supervision, and shipping expenses all of which shall be paid by NeoRx separately.
View Source
Batch Fee. Client shall pay to OXB the applicable Batch Fee for each Batch of Vector in accordance with the payment schedule set out in Schedule 1. [***]. A list of the items included in, and a non-exclusive list of items excluded from, the Batch Fee for each Batch is also shown in Schedule 1.
View Source

Related to Batch Fee

  • Base Fee The Company shall pay to the Advisor a quarterly base fee (the “Base Fee”) payable in arrears in cash, for services provided by the Advisor in the preceding quarter. For purposes of this Agreement, the “Base Fee” will be equal to 0.70% per annum of the Total Market Capitalization of the Company, subject to the payment of a minimum quarterly base fee (“Minimum Base Fee”), if applicable. For purposes of this Agreement, “Total Market Capitalization” shall be calculated on a quarterly basis as (i) the average of the volume-weighted average price per share of Ashford Prime’s common stock for each trading day of the preceding quarter multiplied by the average number of shares of Ashford Prime’s common stock outstanding during such quarter, on a fully-diluted basis (assuming all common units and long term incentive partnership units in the Operating Partnership which have achieved economic parity with common units in the Operating Partnership have been converted to common stock in the Company), plus (ii) the quarterly average of the aggregate principal amount of the Company’s consolidated indebtedness (including the Company’s proportionate share of debt of any entity that is not consolidated but excluding the Company’s joint venture partners’ proportionate share of consolidated debt), plus (iii) the quarterly average of the liquidation value of the Company’s outstanding preferred equity. The Minimum Base Fee for each quarter will be equal to the greater of (i) 90% of the Base Fee paid for the same quarter in the prior year and (ii) the G&A Ratio multiplied by the Company’s Total Market Capitalization. For purposes of this Agreement, the “G&A Ratio” will be calculated as the simple average of the ratios of total general and administrative expenses, less any non-cash expenses but including any dead deal costs, paid in the applicable quarter by each member of a select peer group set forth in Exhibit A (each, a “Peer Group Member” and collectively, the “Peer Group”), divided by the total enterprise value of such Peer Group Member (calculated in the same manner as the Company’s Total Market Capitalization). The G&A Ratio for each Peer Group Member will be calculated based on the financial information presented in such Peer Group Member’s Form 10-Q or 10-K periodic filings with the SEC following the end of each quarter. The Peer Group may be modified from time to time by mutual written agreement of the Advisor and a majority of the Independent Directors, negotiating in good faith. The Base Fee, as calculated above, shall be payable in arrears no later than the 15th day following the end of each quarter (i.e., one-fourth of 0.70% of the Total Market Capitalization of the Company). The Minimum Base Fee shall be calculated as soon as practicable following the end of the quarter, and to the extent the Minimum Base Fee exceeds the Base Fee paid to the Advisor with respect to any quarter, the Company will pay the Advisor the difference between Minimum Base Fee and the Base Fee within 5 business days of final calculation of the Minimum Base Fee. For purposes of payment of the Base Fee for a partial quarter relating to the first quarter in which this Agreement is effective or for the last quarter in which this Agreement is terminated, the Base Fee shall be calculated as 0.70% of the Total Market Capitalization of the Company, calculated using each trading day of such partial quarter prior to termination, multiplied by the number of days in the applicable quarter in which this Agreement is in effect divided by 365 or 366 days, as applicable. The Minimum Base Fee shall be similarly reduced proportionately based on the number of days in the applicable quarter in which this Agreement is in effect divided by 365 or 366 days, as applicable.

  • License Fee The Licensee to shall make payment of the License Fee to Licensor on the date of this Agreement. All rights granted to Licensee by Producer in the Beat are conditional upon Licensee’s timely payment of the License Fee. The License Fee is a one-time payment for the rights granted to Licensee and this Agreement is not valid until the License Fee has been paid.

  • Processing Fee ▇▇▇▇▇▇▇▇ agrees to pay Purchaser the Processing Fee listed on the first page of this Agreement to reimburse Purchaser for expenses incurred in processing Merchant’s application, providing toll-free access to customer service representatives, filing and terminating UCC financing statement(s) against Merchant and fees that Purchaser pays any other person for referring Merchant to Purchaser and assisting with the origination of the sale of the Future Receipts. Purchaser will deduct the amount of the Processing Fee from the Purchase Price that is to be paid to Merchant.

  • Services Fee 5.1 The Transmission Services performed by TSO to Network User under this Standard Transmission Agreement are subject to the applicable Services fee calculated in accordance with attachment A of the Access Code for Transmission. In the event of any modification to the Regulated Tariffs, the Total Monthly Fee(s) and the Total Monthly Self-billing Fee(s) provided for in this Article 5.1 shall be adapted as from the calendar day of the entering into force of the modifications.

  • Monthly Fee The fee for the parking spaces shall be $ per month for parking space(s). each all